IL122466A0 - Therapy using lymphotoxin and thrombopoietin - Google Patents

Therapy using lymphotoxin and thrombopoietin

Info

Publication number
IL122466A0
IL122466A0 IL12246696A IL12246696A IL122466A0 IL 122466 A0 IL122466 A0 IL 122466A0 IL 12246696 A IL12246696 A IL 12246696A IL 12246696 A IL12246696 A IL 12246696A IL 122466 A0 IL122466 A0 IL 122466A0
Authority
IL
Israel
Prior art keywords
lymphotoxin
thrombopoietin
therapy
Prior art date
Application number
IL12246696A
Other languages
English (en)
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of IL122466A0 publication Critical patent/IL122466A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0644—Platelets; Megakaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/145—Thrombopoietin [TPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/25—Tumour necrosing factors [TNF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
IL12246696A 1995-06-06 1996-06-03 Therapy using lymphotoxin and thrombopoietin IL122466A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47077695A 1995-06-06 1995-06-06

Publications (1)

Publication Number Publication Date
IL122466A0 true IL122466A0 (en) 1998-06-15

Family

ID=23868980

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12246696A IL122466A0 (en) 1995-06-06 1996-06-03 Therapy using lymphotoxin and thrombopoietin

Country Status (8)

Country Link
EP (1) EP0831887B1 (fr)
JP (1) JPH11506747A (fr)
AU (1) AU697960B2 (fr)
CA (1) CA2220336A1 (fr)
DE (1) DE69619522T2 (fr)
IL (1) IL122466A0 (fr)
WO (1) WO1996039171A1 (fr)
ZA (1) ZA964382B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102280994B1 (ko) * 2019-12-16 2021-07-22 연세대학교 산학협력단 트롬보포이에틴을 포함하는 탈모 방지 또는 발모 촉진용 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2285446B (en) * 1994-01-03 1999-07-28 Genentech Inc Thrombopoietin
US5747023A (en) * 1994-07-01 1998-05-05 Genentech, Inc. Cancer therapy using lymphotoxin

Also Published As

Publication number Publication date
CA2220336A1 (fr) 1996-12-12
JPH11506747A (ja) 1999-06-15
DE69619522D1 (de) 2002-04-04
ZA964382B (en) 1997-12-01
AU697960B2 (en) 1998-10-22
DE69619522T2 (de) 2002-10-24
WO1996039171A1 (fr) 1996-12-12
EP0831887B1 (fr) 2002-02-27
AU5966796A (en) 1996-12-24
EP0831887A1 (fr) 1998-04-01

Similar Documents

Publication Publication Date Title
GB2298422B (en) Compounds and their use
ZA966494B (en) New drugs and their use
PL327610A1 (en) Quinoline and quinozoline compounds useful in therapy
EP0768038A3 (fr) Graisse de cuisson et son application
IL118442A0 (en) Triazolymethyl-cyclopentanols their preparation and use
PL320565A1 (en) Substances and their application
IL118441A0 (en) Triazolymethyl-oxiranes their preparation and use
ZA962768B (en) Benzonitriles and benzofluorides
EP0836617A4 (fr) Parevines et tachytegrines
GB9514816D0 (en) Substances and their medical use
AU2512495A (en) Therapeutic phenoxyalkylazoles and phenoxyalkylazines
EP0744125A3 (fr) Complexe d'iode et son application
IL122686A0 (en) Benzylhydroxylamines their preparation and use
IL118444A0 (en) Mercapto-triazolyl-silanes their preparation and use
ZA986047B (en) 6-pyrrolidin-2-ylpyrindines their preparation and their therapeutic application
IL122466A0 (en) Therapy using lymphotoxin and thrombopoietin
IL118629A0 (en) N-Substituted cis-N-propenyl-acetemides their preparation and use
GB9523066D0 (en) Compounds and their therapeutic use
GB9526407D0 (en) Substances and their uses
GB9616504D0 (en) Therapeutic product and its use
GB9525891D0 (en) Therapeutic agents and their preparation
GB9609521D0 (en) Substances and their therapeutic use
GB9621314D0 (en) Substances and their therapeutic use
ZA968436B (en) Peptidyl compounds and their therapeutic use.
ZA963739B (en) Peptidyl compounds and their therapeutic use